Max Drawdown (5Y) Chart

View Max Drawdown (5Y) for DXCM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Max Drawdown (5Y) Chart
Start Trial

Historical Max Drawdown (5Y) Data

View and export this data back to 2005. Start Trial.
Date Value
July 31, 2026 66.32%
June 30, 2026 66.32%
May 31, 2026 66.32%
April 30, 2026 66.32%
March 31, 2026 66.32%
February 28, 2026 66.32%
January 31, 2026 66.32%
December 31, 2025 66.32%
November 30, 2025 66.32%
October 31, 2025 64.24%
September 30, 2025 63.25%
August 31, 2025 63.25%
July 31, 2025 63.25%
June 30, 2025 63.25%
May 31, 2025 63.25%
April 30, 2025 63.25%
March 31, 2025 60.69%
February 28, 2025 60.69%
January 31, 2025 60.69%
December 31, 2024 60.69%
November 30, 2024 60.69%
October 31, 2024 60.69%
September 30, 2024 60.69%
August 31, 2024 60.69%
July 31, 2024 60.69%
Date Value
June 30, 2024 58.24%
May 31, 2024 58.24%
April 30, 2024 58.24%
March 31, 2024 58.24%
February 29, 2024 58.24%
January 31, 2024 58.24%
December 31, 2023 58.24%
November 30, 2023 58.24%
October 31, 2023 58.24%
September 30, 2023 58.24%
August 31, 2023 58.24%
July 31, 2023 58.24%
June 30, 2023 58.24%
May 31, 2023 58.24%
April 30, 2023 58.24%
March 31, 2023 58.24%
February 28, 2023 58.24%
January 31, 2023 58.24%
December 31, 2022 58.24%
November 30, 2022 58.24%
October 31, 2022 58.24%
September 30, 2022 58.24%
August 31, 2022 58.24%
July 31, 2022 58.24%
June 30, 2022 58.24%

Max Drawdown Definition

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
Abbott Laboratories 39.63%
Insulet Corp. 61.31%
Baxter International, Inc. 80.60%
Globus Medical, Inc. 47.91%
Stryker Corp. 31.68%